Shanghai Kindly Medical Instruments Co., Ltd. Class H (HK:1501)
:1501
Want to see HK:1501 full AI Analyst Report?
1501 Stock Chart & Stats
HK$29.30
HK$0.10(0.37%)
At close: 4:00 PM EST
HK$29.30
HK$0.10(0.37%)
Day’s Range― - ―
52-Week RangeHK$20.10 - HK$41.40
Previous CloseN/A
Volume37.20K
Average Volume (3M)29.01K
Market Cap
HK$6.72B
Enterprise ValueHK$4.59B
Total Cash (Recent Filing)HK$630.81M
Total Debt (Recent Filing)HK$716.26M
Price to Earnings (P/E)21.7
Beta>-0.01
Next Earnings
Aug 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.21
Shares Outstanding211,200,000
10 Day Avg. Volume19,260
30 Day Avg. Volume29,013
Financial Highlights & Ratios
PEG Ratio1.47
Price to Book (P/B)2.35
Price to Sales (P/S)4.40
P/FCF Ratio16.87
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.39
Revenue Forecast (FY)HK$1.23B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthThe company delivered accelerating top-line growth (12.7% in 2025), indicating expanding product adoption and steady demand for medical consumables. Durable revenue expansion supports scale, recurring consumable sales, and revenue visibility across hospital channels over the next 2–6 months.
Improved Cash GenerationA meaningful rebound in operating cash flow (~341m) and FCF (~278m) in 2025 demonstrates stronger cash conversion and internal funding capacity. Higher, sustained FCF improves ability to invest, service liabilities, and support operations without relying solely on external financing.
Meaningful Equity And Steady ROEA sizeable equity base (~2.0bn) and consistent ROE (~10–11%) provide a capital cushion and show the business can generate acceptable shareholder returns. This structural strength enhances solvency and underpins long-term strategic investments and partner confidence.
Bears Say
Sharp Rise In LeverageDebt more than doubled in 2025, materially increasing leverage and reducing financial flexibility. Higher interest and principal obligations heighten sensitivity to earnings volatility and constrain the company’s ability to fund growth or weather macro shocks without curbing investment or raising costs.
Margin Compression TrendA clear multi-year decline in margins (net margin down from ~33.9% to ~20.5%) suggests rising input costs, pricing pressure, or product-mix shifts. Sustained margin erosion would reduce cash flow per revenue dollar, weakening investment capacity and returns unless cost structure or pricing is addressed.
Volatile Historical Cash FlowAlthough 2025 shows strong FCF, prior years had negative free cash flow, pointing to volatile working capital or capex cycles. Persistent FCF swings complicate forecasting, raise refinancing risk under stress, and make consistent funding of dividends, buybacks, or buy-and-build strategies less reliable.
Shanghai Kindly Medical Instruments Co., Ltd. Class H News
1501 FAQ
What was Shanghai Kindly Medical Instruments Co., Ltd. Class H’s price range in the past 12 months?
Shanghai Kindly Medical Instruments Co., Ltd. Class H lowest stock price was HK$20.10 and its highest was HK$41.40 in the past 12 months.
What is Shanghai Kindly Medical Instruments Co., Ltd. Class H’s market cap?
Shanghai Kindly Medical Instruments Co., Ltd. Class H’s market cap is HK$6.72B.
When is Shanghai Kindly Medical Instruments Co., Ltd. Class H’s upcoming earnings report date?
Shanghai Kindly Medical Instruments Co., Ltd. Class H’s upcoming earnings report date is Aug 14, 2026 which is in 57 days.
How were Shanghai Kindly Medical Instruments Co., Ltd. Class H’s earnings last quarter?
Shanghai Kindly Medical Instruments Co., Ltd. Class H released its earnings results on Mar 27, 2026. The company reported HK$0.713 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.713.
Is Shanghai Kindly Medical Instruments Co., Ltd. Class H overvalued?
According to Wall Street analysts Shanghai Kindly Medical Instruments Co., Ltd. Class H’s price is currently Overvalued.
Does Shanghai Kindly Medical Instruments Co., Ltd. Class H pay dividends?
Shanghai Kindly Medical Instruments Co., Ltd. Class H pays a Annually dividend of HK$0.26 which represents an annual dividend yield of N/A. See more information on Shanghai Kindly Medical Instruments Co., Ltd. Class H dividends here
What is Shanghai Kindly Medical Instruments Co., Ltd. Class H’s EPS estimate?
Shanghai Kindly Medical Instruments Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shanghai Kindly Medical Instruments Co., Ltd. Class H have?
Shanghai Kindly Medical Instruments Co., Ltd. Class H has 211,200,000 shares outstanding.
What happened to Shanghai Kindly Medical Instruments Co., Ltd. Class H’s price movement after its last earnings report?
Shanghai Kindly Medical Instruments Co., Ltd. Class H reported an EPS of HK$0.713 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.386%.
Which hedge fund is a major shareholder of Shanghai Kindly Medical Instruments Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:1501
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Shanghai Kindly Medical Instruments Co., Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.09%
12-Months-Change
Fundamentals
Return on Equity
11.30%
Trailing 12-Months
Asset Growth
45.05%
Trailing 12-Months
Company Description
Shanghai Kindly Medical Instruments Co., Ltd. Class H
Shanghai Kindly Medical Instruments Co., Ltd., founded in 2006 and based in Shanghai, China, focuses on the research, development, production, and international sales of cardiovascular interventional medical devices. The company's products reach customers across Mainland China, Europe, the United States, and various other global regions. Its comprehensive range of interventional instruments includes guiding catheters, which facilitate the introduction of balloon catheters, guidewires, or other therapeutic tools; micro catheters, offering support for guidewire placement; and guidewires themselves, integral to percutaneous transluminal angioplasty (PTA) surgical procedures. The portfolio also features angiography catheters for injecting contrast media and fluids, along with Y-connector packs specifically designed for PTCA surgery. Further product offerings comprise inflation devices, essential for balloon inflation during vessel dilation or stent deployment; single-use manifolds and manifold kits; and pressure bandages utilized for compression hemostasis. The company additionally manufactures single-use angiography syringes, stopcocks for surgical pressure monitoring, sterile Seldinger needles for arterial puncture, introducer sets, single-use pressure transducers, extension tubes for pressure monitoring, and introducer tool kits employed in percutaneous vertebroplasty. Beyond these specialized tools, Shanghai Kindly Medical Instruments provides a variety of medical accessories, such as check valves, needle-free connectors, male Luer locks, bi-stoppers, Heparian caps, flush devices, and flow regulators. Its broader product selection covers items like joint intervention kits, disposable respirator masks, vaginal dilators (for examinations), Foley catheters, infusion pumps, disposable automatic umbilical cord clamps, single-use infusion connectors and accessories, and burette infusion sets (without needles). Serving medical device manufacturers and other clients, the company operates as a subsidiary of Shanghai Kindly Enterprise Development Group Co., Ltd.
Shanghai Kindly Medical Instruments Co., Ltd. Class H (1501) Earnings & Revenues
Technical Analysis
Shandong Weigao Group Medical Polymer Co
―
PW Medtech Group Ltd.
―
Modern Dental Group Limited
―
Angelalign Technology Inc.
―
OrbusNeich Medical Group Holdings Limited
―
Options Prices
Currently, No data available
---